Unique, interactive and totally free, ecancermedicalscience brings to you ecancer tv, turning science to life through multimedia, multi channel delivery.
Watch live surgery, new imaging techniques, interviews from our editorial board and much more, straight from ecancermedicalscience.
View highlights from the 6th European Breast Cancer Conference (EBCC 6).
ECCO and ESMO join forces: Alexander M.M. Eggermont president of ECCO, and José Baselga, president of ESMO, discuss the new initiative between their organisations.
ECCO and ESMO join forces: Michel Ballieu, CEO of ECCO, and Åge Schultz, Executive Director of ESMO, discuss the new collaboration.
The Eurocan+Plus final report: Published after 2 years of investigation and consultation on Europe-wide cancer research. The World Health Organisation backed the report through the International Agency for Research on Cancer (IARC), described by IARC head Dr Peter Boyle as "one of the most significant steps Europe can take in its fight against cancer"
Professor John Crown, consultant medical oncologist at St Vincent Hospital, Dublin, talks about clinical trials of new breast cancer drug lapatinib.
Cancer epidemic on the way Professor Peter Boyle, Director of The International Agency for Research on Cancer (IARC), Lyon.
The new ECCO launches in Barcelona with an interview from John Smyth, ECCO 14 Chair.
Prof Ian Judson, Clinical medical oncologist, on the latest new treatment - Trabectedin (Yondelis®) for metastatic or advanced soft tissue sarcoma
Interview with Jan Foubert, President of the European Oncology Nursing Society, on oncology nursing and the importance of patient education.
Prof. Umberto Veronesi talks exclusively about the reasons for founding ecancermedicalscience
Prof. Gordon McVie, Managing Director of ecancermedicalscience, talks about the multidisciplinary nature of cancer care
Prof. Alexander Eggermont, new President of ECCO, discusses the partnership between ECCO & ecms
Michel Ballieu, ECCO's Chief Executive Officer, discusses the move from FECS to ECCO.